Skip to main content

$0.043 0.002 (4.88%)

High

$0.05

Low

$0.04

Trades

61

Turnover

$61,445

Volume

1,415,719
30 June 2023 at 4:10pm
Register to track NOX and receive email alerts.
Subject
NOX Ann: Noxopharm Corporate Presentation

NOX Ann: Cleansing Notice

NOX Ann: Application for quotation of securities - NOX

NOX Ann: DARRT-2 Study Update and Clarification

NOX Ann: The Noxopharm Newsletter June 2021

NOX Ann: Noxopharm Set to Benefit From Novartis ASCO Data

NOX Ann: Becoming a substantial holder

NOX Ann: Change of Director's Interest Notice - FB

NOX Ann: Change of Director's Interest Notice - BP

NOX Ann: Cleansing Notice

NOX Ann: Appendix 2A

NOX Ann: Appendix 3G

NOX Ann: Noxopharm Extraordinary General Meeting Results

NOX Ann: New Independent Trial Data Supports Potential of Veyonda

NOX Ann: Noxopharm to Present to Share Cafe Hidden Gems Webinar

NOX Ann: NOXCOVID Trial Achieves Full Enrolment

NOX Ann: Cleansing Notice

NOX Ann: Appendix 2A

NOX Ann: Veyonda FDA Approved Trial to Commence

NOX Ann: Securities Trading Policy

NOX Ann: Cleansing Notice

NOX Ann: Appendix 2A

NOX Ann: Change of Director's Interest Notice - BP

NOX Ann: Lapsing of Unlisted Options

NOX Ann: Publications Positive Review of Veyonda in Chemotherapy

NOX Ann: Notice of General Meeting/Proxy Form

NOX Ann: March Quarterly Activities Report and Appendix 4C

NOX Ann: Veyonda Showing Potential to Prevent Cytokine Storm

NOX Ann: Pause in Trading

NOX Ann: Cleansing Notice

NOX Ann: Appendix 2A

NOX Ann: Veyonda Patent Lodged for Major Septic Shock Opportunity

NOX Ann: Corporate Presentation for Switzer Virtual Investor Day

NOX Ann: Noxopharm IONIC Immuno-Oncology Trial Commences

NOX Ann: ASX Small-Mid Cap Conference Corporate Presentation

NOX Ann: NOXCOVID Trial Advances to Final Stage

NOX Ann: Noxopharm Presents to H.C. Wainwright Global Conference

NOX Ann: Cleansing Notice

NOX Ann: Appendix 2A

NOX Ann: Noxopharm Receives A$4.59M Federal Gov R&D Tax Rebate

NOX Ann: Proposed issue of Securities - NOX

NOX Ann: Lapsing of Unlisted Options and Shortfall Shares

NOX Ann: Change of Director's Interest Notice - PM

NOX Ann: Change in substantial holding

NOX Ann: Change of Director's Interest Notice - GK

NOX Ann: Cleansing Notice

NOX Ann: Appendix 2A

NOX Ann: Company Announcement Regarding Appendix 3Y Disclosures

NOX Ann: Change in substantial holding

NOX Ann: Change of Director's Interest Notice - GK

Register to track NOX and receive email alerts.

Similar Companies

CSL ...
CSL
CUV
IMM
IMU
MSB
OPT
PAR
PYC
RAC
TLX